Back
Guardant Health 10K Form
Buy
68
GH
Guardant Health
Last Price:
24.68
Seasonality Move:
-1.25%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive GH News And Ratings
See the #1 stock for the next 7 days that we like better than GH
GH Financial Statistics
Sales & Book Value
| Annual Sales: | $563.95M |
|---|---|
| Cash Flow: | $-99.08M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $-0.01 |
| Price / Book: | 0 |
Profitability
| EPS (TTM): | -4.09000 |
|---|---|
| Net Income (TTM): | $-490.76M |
| Gross Margin: | $336.9M |
| Return on Equity: | -328.76% |
| Return on Assets: | -28.08% |
Guardant Health Earnings Forecast
Key Guardant Health Financial Ratios
- The Gross Profit Margin over the past 8 years for GH is 59.74%.
- The Selling, General & Administrative Expenses for GH have been equal to 79.98% of Gross Profit Margin.
- The Research & Development expenses have been 65.11% of Revenue.
- The Interest Expense is -0.54% of Operating Income.
- The Net Earning history of GH is -85.02% of Total Revenues.
- Per Share Earnings over the last 8 years have been positive in 2 years.
Guardant Health Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Health Care Providers & Services |
| Sector: | Health Care |
| Current Symbol: | GH |
| CUSIP: | 40131M |
| Website: | guardanthealth.com |
Debt
| Debt-to-Equity Ratio: | -707.54 |
|---|---|
| Current Ratio: | 6.4 |
| Quick Ratio: | 5.63 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
GH Technical Analysis vs Fundamental Analysis
Buy
68
Guardant Health (GH)
is a Buy
Is Guardant Health a Buy or a Sell?
-
Guardant Health stock is rated a Buy
The current Guardant Health [GH] share price is $23.52. The Score for GH is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.